Company intelligence / Profile preview
Livzon Pharmaceutical Group Inc.
- Ownership
- Public · 000513
- Employees
- ~9067
- Development stage
- Commercial
Overview
Livzon has a broad commercial portfolio with over eighty marketed products across multiple therapeutic areas. Its pipeline includes more than twenty programs in various stages of development. Notably, it developed a recombinant SARS-CoV-2 fusion protein vaccine that has been deployed regionally in China. The company continues to expand its oncology pipeline through partnerships such as the TYK Medicines collaboration for multi-targeted kinase inhibitors targeting resistance mutations in cancer patients
- Therapeutic areas
- OncologyMetabolic DisordersEndocrinologyPsychiatryGastroenterologyInfectious Diseases
- Modalities
- Small moleculesbiologics (including antibody medicines and vaccines)diagnostic reagentsAPIspolypeptides
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Livzon Pharmaceutical Group Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Livzon Pharmaceutical Group Inc..